We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$18.6B
AUM Growth
-$1.59B
Cap. Flow
-$881M
Cap. Flow %
-4.75%
Top 10 Hldgs %
25.83%
Holding
430
New
84
Increased
94
Reduced
203
Closed
27

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$241M
2
TWLO icon
Twilio
TWLO
+$60M
3
XYZ
Block Inc
XYZ
+$50.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$50M
5
SOFI icon
SoFi Technologies
SOFI
+$45.9M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$398M
2
ROKU icon
Roku
ROKU
+$137M
3
MTCH icon
Match Group
MTCH
+$117M
4
GS icon
Goldman Sachs
GS
+$107M
5
ENPH icon
Enphase Energy
ENPH
+$96M

Sector Composition

Rank Sector Weight
1 Technology 26.52%
2 Healthcare 23.41%
3 Consumer Discretionary 18.52%
4 Communication Services 12.03%
5 Miscellaneous 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
351
Allogene Therapeutics
ALLO
$615M
$1K ﹤0.01%
29
-12
-29% -$405
QDEL icon
352
QuidelOrtho
QDEL
$808M
$1K ﹤0.01%
7
-36,924
-100% -$6.82M
ABCL icon
353
AbCellera Biologics
ABCL
$3.62B
– –
-454,598
Closed -$18.3M
AMWL icon
354
American Well
AMWL
$221M
$0 ﹤0.01%
1
-295
-100% -$160K
BFH icon
355
Bread Financial
BFH
$4.09B
– –
-27,051
Closed -$1.6M
BLUE
356
DELISTED
bluebird bio
BLUE
– –
-19
Closed -$11K
EBS icon
357
Emergent Biosolutions
EBS
$319M
– –
-35,069
Closed -$3.14M
EHTH icon
358
eHealth
EHTH
$29.6M
– –
-105,205
Closed -$7.43M
GLD icon
359
SPDR Gold Trust
GLD
$145B
– –
-84,694
Closed -$15.1M
HQY icon
360
HealthEquity
HQY
$7.94B
– –
-22,272
Closed -$1.55M
LPSN
361
DELISTED
LivePerson
LPSN
– –
-67
Closed -$62K
MASS icon
362
908 Devices
MASS
$393M
– –
-17,399
Closed -$991K
PD icon
363
PagerDuty
PD
$1.11B
– –
-141,262
Closed -$5.89M
PDFS icon
364
PDF Solutions
PDFS
$2.02B
– –
-28,645
Closed -$619K
REGN icon
365
Regeneron Pharmaceuticals
REGN
$81.7B
– –
-5,707
Closed -$2.76M
RNR icon
366
RenaissanceRe
RNR
$13.7B
– –
-43
Closed -$7K
SINT icon
367
SiNtx Technologies
SINT
$12M
– –
0
– –
SPWH icon
368
Sportsman's Warehouse
SPWH
$45.4M
– –
-59,483
Closed -$1.04M
TCMD icon
369
Tactile Systems Technology
TCMD
$507M
– –
-2,559
Closed -$115K
WAB icon
370
Wabtec
WAB
$47.8B
$0 ﹤0.01%
+5
New +$388
XYL icon
371
Xylem
XYL
$25.1B
– –
-357,971
Closed -$36.4M
KLRS
372
Kalaris Therapeutics
KLRS
$80.5M
– –
-575
Closed -$509K
MNTV
373
DELISTED
Momentive Global Inc. Common Stock
MNTV
– –
-140,702
Closed -$3.6M
TIG
374
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
– –
-34,545
Closed -$453K
CVET
375
DELISTED
Covetrus, Inc. Common Stock
CVET
$0 ﹤0.01%
8
– –
12 13 14
15
16

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Gilder Gagnon Howe & Co held 430 positions worth $18.6B, down 7.9% from $20.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $881M in Q1 2021, closing 27 positions and reducing 203 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Affirm worth $175M.

  • Gilder Gagnon Howe & Co's largest Q1 2021 buy was Affirm: 2,479,834 shares worth $175M.
  • Gilder Gagnon Howe & Co added most to Twilio in Q1 2021, an estimated $60M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2021 reduction was Tesla, cutting an estimated $398M.
  • Gilder Gagnon Howe & Co fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $43.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $18.6B portfolio in Q1 2021.
  • Gilder Gagnon Howe & Co opened 84 new positions and closed 27 in Q1 2021.
  • Gilder Gagnon Howe & Co's portfolio value fell 7.9% quarter-over-quarter to $18.6B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.